Understanding how specific proteins affect tooth enamel development
Investigating Interactions Between Phosphorylated Amelogenin and Acid Phosphatase 4 Expression
This study is looking at how certain proteins help form strong dental enamel, which is important for people with conditions like amelogenesis imperfecta that cause weak enamel, and it hopes to find new ways to improve dental health.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10899185 on NIH RePORTER |
What this research studies
This research investigates the role of phosphorylated amelogenin and its interaction with acid phosphatase 4 in the development of dental enamel. By using advanced techniques like single cell RNA sequencing and protein analysis, the study aims to uncover the mechanisms behind enamel formation and the impact of pH levels on these processes. Patients with conditions like amelogenesis imperfecta, which leads to weakened enamel, may benefit from insights gained through this research. The findings could help in developing targeted therapies for enamel-related dental issues.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with amelogenesis imperfecta or other enamel hypoplasia conditions.
Not a fit: Patients without enamel-related conditions or those with fully developed and healthy enamel may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for patients suffering from enamel defects, improving dental health and quality of life.
How similar studies have performed: Previous research has shown promising results in understanding enamel formation through similar protein interaction studies, indicating a potential for success in this area.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Vasquez, Brent Preston — University of Pittsburgh at Pittsburgh
- Study coordinator: Vasquez, Brent Preston
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.